Ishii H - Search Results

1

Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial.

Ikeda M, Kudo M, Aikata H, Nagamatsu H, Ishii H, Yokosuka O, Torimura T, Morimoto M, Ikeda K, Kumada H, Sato T, Kawai I, Yamashita T, Horio H, Okusaka T; Miriplatin TACE Study Group. Ikeda M, et al. Among authors: ishii h. J Gastroenterol. 2018 Feb;53(2):281-290. doi: 10.1007/s00535-017-1374-6. Epub 2017 Aug 1. J Gastroenterol. 2018. PMID: 28766016 Free PMC article. Clinical Trial.

2

Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma.

Furuse J, Ishii H, Satake M, Onaya H, Nose H, Mikami S, Sakai H, Mera K, Maru Y, Yoshino M. Furuse J, et al. Among authors: ishii h. Am J Clin Oncol. 2003 Apr;26(2):159-64. doi: 10.1097/00000421-200304000-00012. Am J Clin Oncol. 2003. PMID: 12714888 Clinical Trial.

3

A phase I study of hepatic arterial infusion chemotherapy with zinostatin stimalamer alone for hepatocellular carcinoma.

Ishii H, Furuse J, Nagase M, Maru Y, Yoshino M, Hayashi T. Ishii H, et al. Jpn J Clin Oncol. 2003 Nov;33(11):570-3. doi: 10.1093/jjco/hyg106. Jpn J Clin Oncol. 2003. PMID: 14711981 Clinical Trial.

4

Chemotherapy in the treatment of advanced gallbladder cancer.

Ishii H, Furuse J, Yonemoto N, Nagase M, Yoshino M, Sato T. Ishii H, et al. Oncology. 2004;66(2):138-42. doi: 10.1159/000077440. Oncology. 2004. PMID: 15138366

5

Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.

Ishii H, Furuse J, Nagase M, Kawashima M, Ikeda H, Yoshino M. Ishii H, et al. Hepatogastroenterology. 2004 Jul-Aug;51(58):954-7. Hepatogastroenterology. 2004. PMID: 15239222 Clinical Trial.

6

Hepatic arterial infusion of 5-fluorouracil and extrabeam radiotherapy for liver metastases from pancreatic carcinoma.

Ishii H, Furuse J, Nagase M, Yoshino M, Kawashima M, Satake M, Ogino T, Ikeda H. Ishii H, et al. Hepatogastroenterology. 2004 Jul-Aug;51(58):1175-8. Hepatogastroenterology. 2004. PMID: 15239272 Clinical Trial.

7

Impact of gemcitabine on the treatment of metastatic pancreatic cancer.

Ishii H, Furuse J, Nagase M, Yoshino M. Ishii H, et al. J Gastroenterol Hepatol. 2005 Jan;20(1):62-6. doi: 10.1111/j.1440-1746.2004.03487.x. J Gastroenterol Hepatol. 2005. PMID: 15610448

8

Extrahepatic spread from hepatocellular carcinoma: who are candidates for aggressive anti-cancer treatment?

Ishii H, Furuse J, Kinoshita T, Konishi M, Nakagohri T, Takahashi S, Gotohda N, Nakachi K, Yoshino M. Ishii H, et al. Jpn J Clin Oncol. 2004 Dec;34(12):733-9. doi: 10.1093/jjco/hyh135. Jpn J Clin Oncol. 2004. PMID: 15640504

9

Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.

Kawashima M, Furuse J, Nishio T, Konishi M, Ishii H, Kinoshita T, Nagase M, Nihei K, Ogino T. Kawashima M, et al. Among authors: ishii h. J Clin Oncol. 2005 Mar 20;23(9):1839-46. doi: 10.1200/JCO.2005.00.620. J Clin Oncol. 2005. PMID: 15774777 Clinical Trial.

10

Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin.

Yonemori K, Ueno H, Okusaka T, Yamamoto N, Ikeda M, Saijo N, Yoshida T, Ishii H, Furuse J, Sugiyama E, Kim SR, Kikura-Hanajiri R, Hasegawa R, Saito Y, Ozawa S, Kaniwa N, Sawada J. Yonemori K, et al. Among authors: ishii h. Clin Cancer Res. 2005 Apr 1;11(7):2620-4. doi: 10.1158/1078-0432.CCR-04-1497. Clin Cancer Res. 2005. PMID: 15814642 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,096 results

Search Page